A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

about

Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study.HIV-Associated Neurocognitive Disorders: A Global Perspective.Distribution of HIV RNA in CSF and Blood is linked to CD4/CD8 Ratio During Acute HIV.

P2860

Q38682437-63E0C0E4-7215-4503-8AD1-D1C3E8861D44 Q46077781-DDF7D603-2D15-4075-B6BA-1BB7528819FC Q54217355-1BF2242D-6594-43EF-B821-51251DBF529F

P2860

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

Item

http://www.wikidata.org/entity/Q40463006

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A decreasing CD4/CD8 ratio ove ...... endently of viral replication.

@en

type

Item

label

A decreasing CD4/CD8 ratio ove ...... endently of viral replication.

@en

prefLabel

A decreasing CD4/CD8 ratio ove ...... endently of viral replication.

@en

P1476

A decreasing CD4/CD8 ratio ove ...... endently of viral replication.

@en

P2093

A Harvey-Langton

http://www.w3.org/2001/XMLSchema#string

B Dunais

http://www.w3.org/2001/XMLSchema#string

C Pradier

http://www.w3.org/2001/XMLSchema#string

F DeSalvador

http://www.w3.org/2001/XMLSchema#string

H Joly

http://www.w3.org/2001/XMLSchema#string

J Cottalorda

http://www.w3.org/2001/XMLSchema#string

J Durant

http://www.w3.org/2001/XMLSchema#string

M Laffon

http://www.w3.org/2001/XMLSchema#string

M Ticchioni

http://www.w3.org/2001/XMLSchema#string

Matteo Vassallo

http://www.w3.org/2001/XMLSchema#string

P2860

Human T cell aging and the impact of persistent viral infections

Cognitive neuropsychology of HIV-associated neurocognitive disorders

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets

HIV infection, inflammation, immunosenescence, and aging.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

P2888

s13365-016-0490-z

P304

216-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-016-0490-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine Lebrun-Frenay

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27815816

http://www.w3.org/2001/XMLSchema#string

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

about

P2860

P2860

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698